Business news

    VIDEO: Vir Biotechnology jumped 12% on trial results for its COVID-19 treatment showing effectiveness against the Omicron variant.

    VIDEO: Vir Biotechnology jumped 12% on trial results for its COVID-19 treatment showing effectiveness against the Omicron variant.
    Video Player is loading.
    Current Time 0:12
    Duration 1:24
    Loaded: 65.87%
    Stream Type LIVE
    Remaining Time 1:12
     
    1x
      • Chapters
      • descriptions off, selected
      • captions off, selected
      • default, selected

      The US markets continued to soar on Tuesday as investor optimism that the Omicron variant of COVID-19 will play little impact on economic recovery, remains high. Intel jumped 3% on Tuesday after the multinational semiconductor and tech company revealed plans to take its majority-owned, self-driving subsidiary Mobileye public through an IPO in mid 2022. A spotlight on Vir Biotechnology as the biotech company soared 12% yesterday after announcing with its partner, GlaxoSmithKline, that their COVID-19 antibody treatment proved effective against the Omicron variant of COVID-19 in early-stage lab studies. eBay is introducing a new 3D interactive sneaker viewer allowing sellers to ?scan? their shoes to create a 3D replica for shoppers to get the full view of the shoes they are looking to buy.

      Disclaimer

      Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relates to your unique circumstances. Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of, or reliance on the information provided directly or indirectly by use of this platform.

      Publisher
      Grafa